Tumor Board: Your Team of Experts Working Together for Better Ovarian Cancer Care

When you’re diagnosed with ovarian cancer, a tumor board brings together multiple specialists to review your case and create the most effective treatment plan possible.

If you’ve recently been diagnosed with ovarian cancer, you might hear your doctor mention presenting your case to a “tumor board.” This isn’t something to worry about. Actually, it’s one of the best things that can happen in your cancer journey.

A tumor board is where medicine gets smarter. It’s where your individual case gets the attention of not just one doctor, but an entire team of experts who specialize in different areas of cancer care. They gather to discuss your diagnosis, review your test results, and figure out the best path forward together.

What Is a Tumor Board?

A tumor board (also called a multidisciplinary team meeting or cancer conference) is a scheduled meeting where specialists from various medical fields come together to discuss complex cancer cases. Think of it as a strategy session focused entirely on finding the best treatment approach for you.

These meetings happen regularly at cancer centers — some weekly, others bimonthly — depending on the hospital’s schedule and patient volume. The format can vary, too. Some tumor boards meet in person, while others connect virtually through video conferencing, which has become increasingly common and effective.

The goal is straightforward: get multiple expert opinions in one room so nothing gets missed and every treatment option gets considered.

Who Attends a Tumor Board Meeting?

Your tumor board isn’t just two or three doctors chatting in a hallway. It’s a formal gathering of specialists who each bring unique expertise to your case:

• Gynecologic oncologists who specialize in ovarian cancer treatment and surgery
• Medical oncologists who manage chemotherapy and targeted therapies
• Radiation oncologists who design radiation treatment plans
• Pathologists who analyze your biopsy and tissue samples
• Radiologists who interpret your imaging scans (CT, MRI, PET)
• Genetic counselors who assess hereditary risk factors like BRCA mutations
• Clinical trial coordinators and research staff who identify trial eligibility and screening opportunities
• Nurse navigators who coordinate your care
• Social workers who provide emotional and practical support

Depending on your specific situation, other specialists might join, too: like palliative care doctors, nutritionists, or fertility specialists if you’re facing treatment-induced menopause or considering fertility-sparing surgery in ovarian cancer.

This collaboration among healthcare professionals from different specialties helps create comprehensive treatment plans and identify the most effective cancer treatment strategy for each patient.  

What Happens at a Tumor Board?

During the meeting, specialists review everything about your case:

Your medical history. They look at your age, overall health, any other medical conditions, and family history of cancer.

Diagnostic test results. This includes your biopsy findings, imaging scans, CA-125 ovarian cancer screening results, and any genetic testing that’s been done. If you’ve had BRCA testing for ovarian cancer, those results get discussed, too.

Cancer staging and type. The team confirms whether you have borderline ovarian cancer, low-grade serous ovarian cancer, epithelial ovarian cancer, or another subtype. Understanding ovarian cancer staging is crucial because it influences treatment decisions.

Treatment options. The team discusses surgery, chemotherapy, targeted therapies like PARP inhibitors, hormone therapy, and whether you might be eligible for ovarian cancer clinical trials.

Each specialist shares their perspective. The radiologist might point out something subtle on your scan. The pathologist might explain unique characteristics of your tumor cells. The gynecologic oncologist might suggest a specific chemotherapy regimen and discuss whether debulking surgery is appropriate — since they typically manage both the surgical and chemotherapy aspects of ovarian cancer treatment.

This collaborative review often leads to changes in diagnosis or treatment plans. Studies have shown that tumor board discussions result in modified treatment recommendations in a significant percentage of cases, leading to more accurate staging and more appropriate care.  

Does Every Ovarian Cancer Case Go to Tumor Board?

Not necessarily. First, tumor boards are primarily found at academic medical centers, research hospitals, and large cancer treatment centers. Many community hospitals don’t have formal tumor board programs, which means access depends largely on where you receive care.

Even at hospitals that do have tumor boards, not every case gets presented. When a diagnosis is straightforward and the treatment path follows standard protocols, your oncologist might proceed without a full tumor board review.

But many situations benefit from this collective expertise:

• Rare or unusual cancer types 
• Advanced-stage cancer requiring complex treatment planning
• Cases where initial treatment hasn’t worked as expected
• Young patients facing difficult decisions about fertility preservation
• Situations involving multiple health conditions that complicate treatment
• When genetic factors might influence treatment options

If you have low-grade serous ovarian cancer, tumor board discussion becomes especially valuable since this subtype often responds differently to standard treatments than high-grade cancers.

Why Tumor Boards Matter for Ovarian Cancer Patients

The research is clear: tumor boards improve outcomes.

Better diagnosis. Multiple specialists reviewing your case means greater accuracy in both diagnosis and staging. Sometimes imaging gets reinterpreted. Pathology gets a second look. These reviews catch things that might otherwise be missed.

More appropriate treatment. Studies show that tumor board discussions increase adherence to clinical guidelines and often lead to more evidence-based treatment plans.

Faster care. When all your specialists are on the same page from the start, it reduces delays and conflicting recommendations. You’re not bouncing between offices trying to coordinate separate opinions.

Access to innovation. Tumor boards often discuss clinical trial eligibility. Your case might be perfect for a new treatment being studied. Without that discussion, the opportunity might be missed.

Your Role in the Process

After the tumor board meets, your oncologist will discuss their recommendations with you. 

This is when you ask questions, share your concerns, and express your preferences. Maybe fertility preservation is critical to you. Maybe you’re worried about how to manage ovarian cancer chemotherapy side effects. Maybe you want to understand the different treatment approaches being discussed or why a surgical oncologist might be consulted for particularly complex cases.

Finding Care at Centers with Tumor Boards

When choosing your gynecologic oncologist, ask whether they participate in regular tumor boards. Top cancer centers — Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, Cleveland Clinic — all have robust tumor board programs.

But you don’t necessarily need to travel to a major city. Many community cancer centers now conduct tumor boards, and some participate in virtual tumor boards that connect them with specialists at larger institutions.

Research shows that virtual tumor boards have significantly increased participation, with overall attendance increasing by 46% on virtual platforms compared to in-person meetings, making it easier for community providers to access expert specialist advice without geographic barriers.

The key is finding a team that takes a collaborative approach to your care. One where communication flows freely between specialists. One where your case gets the attention and expertise it deserves.

At Not These Ovaries, we believe every patient deserves access to this kind of comprehensive, expert care. That’s why we fund research focused on improving ovarian cancer treatment options, especially for the rarer, underresearched subtypes that primarily affect younger women. Because when we improve the science, we improve the care. And when we improve the care, we save lives.